Fulgent Genetics Current Valuation vs. Shares Owned By Institutions
| FLGT Stock | USD 20.24 0.11 0.55% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.44 | 0.3612 |
|
|
For Fulgent Genetics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Fulgent Genetics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Fulgent Genetics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Fulgent Genetics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Fulgent Genetics over time as well as its relative position and ranking within its peers.
Fulgent |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (5.52) | Revenue Per Share 9.255 | Quarterly Revenue Growth (0.15) | Return On Assets (0.04) |
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fulgent Genetics Shares Owned By Institutions vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Fulgent Genetics's current stock value. Our valuation model uses many indicators to compare Fulgent Genetics value to that of its competitors to determine the firm's financial worth. Fulgent Genetics is rated below average in current valuation category among its peers. It is rated below average in shares owned by institutions category among its peers . The ratio of Current Valuation to Shares Owned By Institutions for Fulgent Genetics is about 7,576,354 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Fulgent Genetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Fulgent Current Valuation vs. Competition
Fulgent Genetics is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 591.7 Billion. Fulgent Genetics adds roughly 411.69 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Fulgent Shares Owned By Institutions vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Fulgent Genetics |
| = | 411.69 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Fulgent Genetics |
| = | 54.34 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Fulgent Shares Owned By Institutions Comparison
Fulgent Genetics is currently under evaluation in shares owned by institutions category among its peers.
Fulgent Genetics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Fulgent Genetics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Fulgent Genetics will eventually generate negative long term returns. The profitability progress is the general direction of Fulgent Genetics' change in net profit over the period of time. It can combine multiple indicators of Fulgent Genetics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.2 M | 1.3 M | |
| Operating Income | -72.7 M | -69.1 M | |
| Net Loss | -65 M | -61.7 M | |
| Income Before Tax | -174.1 M | -165.4 M | |
| Total Other Income Expense Net | -101.4 M | -96.3 M | |
| Net Income Applicable To Common Shares | 164.9 M | 101.5 M | |
| Net Loss | -167.8 M | -159.4 M | |
| Income Tax Expense | 1.2 M | 1.1 M | |
| Interest Income | 18.6 M | 19.5 M | |
| Net Interest Income | 18.6 M | 19.5 M | |
| Non Operating Income Net Other | 5.8 M | 6.1 M | |
| Change To Netincome | 86.8 M | 91.1 M | |
| Net Loss | (5.63) | (5.35) | |
| Income Quality | (0.16) | (0.17) | |
| Net Income Per E B T | 0.96 | 1.45 |
Fulgent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Fulgent Genetics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Fulgent Genetics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Fulgent Genetics' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Fulgent Genetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Use Investing Themes to Complement your Fulgent Genetics position
In addition to having Fulgent Genetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.